TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: mean number of dollars lost per month
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: mean number of gambled days per month
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: greatest dollar amount gambled on any day
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: total CGPI score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Safety of combined gemcitabine chemotherapy with IV ascorbate
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline on the Boston Naming Test within one week of intervention completion
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change from baseline on the Boston Naming Test at 3 months
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Degree of torn internal urethral sphincter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Videofluoroscopy results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Critical closing pressure (PCrit)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TB Treatment Success Rates
Endpoint domain: Mortality/survival
Primary endpoint: Organoleptic valuations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ultrasound examination (gallbladder, stomach) and orocecal transit time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of Participants With Relapse of Major Depressive Episode Within 1 Year
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of Participants Achieving and Maintaining an sUA ≤ to 6 mg/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Center of pressure path length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of PELD scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of albumin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change of total bilirubin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heroin relapse
Endpoint domain: Adverse events/effects
Primary endpoint: Change in muscle thickness of pectoral and rectus abdominis muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Pathological staging assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Tenofovir Diphosphate (TFV-DP) Drug Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in depression symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in quality of self-perceived sleep
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Safety of NK DLI Infusion
Endpoint domain: Adverse events/effects
Primary endpoint: Change in red blood cell count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in white blood cell count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Percentage of Tested Patients
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number (%) Infected
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Timeliness of Testing
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Total healthcare expenditures per patient
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Total drug costs per patient
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Drug cost to total healthcare expenditure ratio
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: H-score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Procedural related Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: PAH related adverse events and all cause death
Endpoint domain: Mortality/survival
Primary endpoint: Presence of microbial substances in stool samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: single leg test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tetrax Balance Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 50 feet walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower extremity function scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Incidence of mucositis grade
Endpoint domain: Adverse events/effects
Primary endpoint: Cerebral activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage of Participants Achieving American College of Rheumatology 50% (ACR50) Response at Week 52
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Failure rates of system components
Endpoint domain: Adverse events/effects
Primary endpoint: Modified Rankin Scale (mRS) 0-1
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: H Pylori eradication rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Pharmacokinetics of CKD-4101 tablet and Mycophenolate Mofetil capsule
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation of Placebo-adjusted Change From Pre-dose Value in Lactate Versus Metformin Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of help seeking in intervention group
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of confirmed psychiatric diagnoses in intervention group
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dose Limiting Toxicity of PY159
Endpoint domain: Adverse events/effects
Primary endpoint: Current knee pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in quality of life (KDQOL-PCS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Timed 25-foot Walk Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Psychological distress measured by Kessler Psychological Distress Scale (K10)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Occurrence of anticipated and unanticipated adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Subject feedback regarding the safety of using the device
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: EuroQol-5 Dimensions visual analogue scale score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: EuroQol-5 Dimensions index score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in pulmonary functions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Successful pulmonary vein isolation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Strength related parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Adverse Events Considered Probably or Possibly Related to Study Drug
Endpoint domain: Adverse events/effects
Primary endpoint: Pancreatic Fat Content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Bone Turnover Marker - Intact Parathyroid Hormone (PTH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Bone Turnover Marker - Plasma 25-hydroxyvitamin D
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Changes in axial length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Remission rate (cytologic)
Endpoint domain: Mortality/survival
Primary endpoint: Remission rate (molecular)
Endpoint domain: Mortality/survival
Primary endpoint: Recanalization rate of PVT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Changes in MMS after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients starting allocated care pathway
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Relative volume of intramuscular fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preprandial metabolic
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change of food perceptions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improved adherence to antiretroviral treatment regimen
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Subsets and activation status of B, T, and NK lymphocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Nonrelapse Mortality
Endpoint domain: Mortality/survival
Primary endpoint: American Shoulder and Elbow Surgeon Outcome
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Hospitalization within 14 days of enrollment
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of subjects able to complete treatment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Risk of peptic ulcer bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Diagnostic yield of EBUS-guided TBNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Insulin stimulated uptake of glucose in adipose tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Hyperinsulinemic euglycemic clamp
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Range of limits of stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensory Organization Test (SOT) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Root mean square (RMS) of postural sway
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline DVR at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline SUVR at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline NAA at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Protein expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Patients With Cerebrovascular Events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Patients With Cardiovascular Events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 13CO2 excretion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of melasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: abnormal thiamin pyrophosphate effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: AUC of post-dose FEV1 percentage changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change From Baseline in Mean Central Neuropathic Pain Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Overall quality of bowel cleansing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Correction of Nasolabial
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success of intubation on first attempt
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Dose intensity of chemoradiotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of cUck2 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dyspnea Numeric Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primary Myeloma Endpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Area under the Receiver Operating Characteristics Curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cortical Thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cortical Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: morphine-sparing effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Isokinetic strength test of extension of the injured leg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Relative strength extension ratio (injured/uninjured)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Distance of the jump achieved in the single leg hop
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Time to achieve the shuttle run
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Multidimensional fatigue inventory (MFI)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Actual working length (AWL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time without recurrence
Endpoint domain: Mortality/survival
Primary endpoint: Number of Participants With Antibodies Against Diphtheria and Tetanus at ≥ 1.0 IU/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Geometric Mean Titers (GMTs) of Antibodies Against Meningococcal Serogroups A, C, Y, and W-135
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Time to Resolution of Parenteral Nutrition Associated Cholestasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Growth Z-scores for Weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in galvanic skin response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with localization wire placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in brain NAD+/NADH ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Postoperative requirement of analgesic tilidine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacokinetics of Symlin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and tolerability of Symlin
Endpoint domain: Adverse events/effects
Primary endpoint: Stroke volume (ml)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cardiac output (l/min)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time to Maximum Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Curve for the 24-hour Dosing Interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Elimination Rate Constant
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nordic Musculoskeletal Questionnaire scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Occupational Fatigue Exhaustion Recovery Scale scores
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Sleep Hygiene Index score
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: WHOQOL-BREF-TR scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Serum IL-6 and CRP levels before and after operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cosmetic outcomes after surgery
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Percentage of magnetic interference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Common bile duct pressures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Continuous Four-week Abstinence From Smoking
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Geometric Mean Ratio of % Liver Fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Health status (WHO classification)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patency of the bile duct
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Durable Clinically Meaningful Platelet Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Cmax-am for Oral TU
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Time of Peak Concentration (Tmax-am)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Area Under the Curve (AUC-am)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Time Weighted Average Total Testosterone Concentration (Cavg-am)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Total body pool size vitamin A
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Liver Vitamin A store
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of patients who achieved target weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Upregulation or Downregulation of Gene Expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of Relapses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Confirmed Disease Progression (CDP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree of stent strut coverage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentrations of trace elements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Opioid Pain Medications Required 0-3h Post op in Morphine Milligram Equivalents (MME)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Opioid Pain Medications Required Through 3-24h Post op in MME
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PSA recurrence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: EGFR overexpression rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: HER2/neu overexpression rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Stroke Specific Quality of Life Scale (SSQOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Dropout Rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Accuracy of staging lung cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peripheral and central blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Immune parameters of participants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Viral parameters of participants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: progression-free survival rate at 6 months
Endpoint domain: Mortality/survival
Primary endpoint: S-100B
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: NSE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Outcome of chronic HBV infection
Endpoint domain: Mortality/survival
Primary endpoint: hemoglobin oxygen saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: cerebral metabolic rate of oxygen consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Safety in terms of adverse events and dose-limiting toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: EMG of biceps brachii
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: EMG of triceps brachii
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: EMG of pectoralis major
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: MyotonPRO measurement of pectoralis major muscle tone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Mean surgical rating score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: AUC0-tz of Free Dabigatran
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes